Suchergebnisse - "Glioma"

PubPharm (39.696)

31

Engineered Cell Membrane-Coated Nanoparticles : New Strategies in Glioma Targeted Therapy and Immune Modulation

enthalten in: Advanced healthcare materials | 2024

von Ma, Y. | Yi, J. | Ruan, J. | +11

32

The downregulation of Kv1 channels in Lgi1-/-mice is accompanied by a profound modification of its interactome and a parallel decrease in Kv2 channels

enthalten in: Neurobiology of disease | 2024

von Ramirez-Franco, J. | Debreux, K. | Sangiardi, M. | +6

33

Anti-cancer potential of zerumbone in cancer and glioma: current trends and future perspectives

enthalten in: Medical oncology | 2024

von Soroush, A. | Pourhossein, S. | Hosseingholizadeh, D. | +8

34

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) : Molecular Analysis for Therapy Choice (MATCH)

enthalten in: ClinicalTrials.gov | 2024

35

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma : A Phase 2 Study of Dabrafenib (NSC# 763760) With Trametinib (NSC# 763093) After Local Irradiation in Newly-Diagnosed BRAF V600-Mutant High-Grade Glioma (HGG)

enthalten in: ClinicalTrials.gov | 2024

36

A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden : A Phase II Study of Checkpoint Blockade Immunotherapy in Patients With Somatically Hypermutated Recurrent WHO Grade 4 Glioma

enthalten in: ClinicalTrials.gov | 2024

37

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma : A Phase 1/2 Trial of CBL0137 (NSC# 825802) in Patients With Relapsed or Refractory Solid Tumors Including CNS Tumors and Lymphoma

enthalten in: ClinicalTrials.gov | 2024

38

Multi-scale feature fusion for prediction of IDH1 mutations in glioma histopathological images

enthalten in: Computer methods and programs in biomedicine | 2024

von Liu, X. | Hu, W. | Diao, S. | +3

39

Glioma segmentation based on dense contrastive learning and multimodal features recalibration

enthalten in: Physics in medicine and biology | 2024

von Hu, X. | Wang, L. | Wang, L. | +3

40

REVOLUMAB : A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Picca, A. | Touat, M. | Belin, L. | +13